Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Applied Bioplastics has developed and commercialized plant-based polymers that replace up to 30% of petrochemical content in plastics. Their materials have been used in large-scale applications such as building materials for refugee shelters and are currently being trialed by the United Nations. The technology can reduce CO2 emissions from plastic manufacturing by up to 97% compared to traditional methods.
Their biocomposites are less expensive than commodity plastics while maintaining or improving physical properties and integrate seamlessly with existing industry equipment.
No clinical results as the company does not operate in healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Applied Bioplastics.